TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Bailes: ASCO To Strengthen State Affiliates, Begin Quality Of Care Study, Talk With FDA. May 26, 2000
TCL Archive NCI Contract Process Requires Eight Months, Probably Will Get Longer As Program Grows February 8, 1974
TCL Archive NCAB Hears Good News: FY 92 Budget Allows NCI To Increase Levels Of Most Programs November 29, 1991